Ozempic-maker Novo Nordisk slims down to 'Novo' / Photo: Michal Cizek - AFP
-
International Trading Institute Expands Professional Trader Development Beyond the Master’s in Trading
-
FX Junction Reaches 40,600 Members and 26 Million Trades
-
Nairobi to host 2029 world athletics championships in African first
-
Prominent Greek neo-Nazi exits prison, vows return to politics
-
Ukraine winemakers defy war to make a splash at home
-
'Obsessed': explosive state crime inquiry grips South Africa
-
Prominent Greek neo-Nazi exits prison, vows return to politics: AFP
-
Sri Lanka's javelin champ returns to 'broken' welcome
-
Saudi Arabia vows to respond 'firmly' to Houthi attacks
-
Lake Energy Secures $80 Million for U.S. Renewable Energy Expansion
-
'We unleashed the beast': the world's fears and hopes about AI
-
Huge Van Gogh collection reunited for first time since 1984
-
Carragher sees Manchester City’s winning start as challenge to Arsenal
-
Stocks drop, oil climbs and Treasury yields hit 19-year high
-
Oasis fans weigh ticket costs and reunion memories ahead of 2027 tour
-
Asian Games cruise ship arrives as accommodation complaints grow
-
EastEnders previews Kat’s grief after Zoe’s death
-
Giggs names Odegaard as favourite Arsenal player after strong start
-
US military confirms Iran war has led to munitions shortfall
-
Hospitality leaders ask Burnham to halve VAT amid rising costs
-
SkySail Strategies Outperforms Wall Street's 30-Year Risk Standard With Proprietary AI Inference Model
-
Worcestershire invited to nominate groups for 2027 King’s volunteer award
-
Canada ends refugee family sponsorship exemption over integrity concerns
-
Just add fish: Scientists pursue more rice, less disease in Senegal paddies
-
Berlin's run-down public spaces at heart of election campaign
-
Louisville adds LJ Wells for fifth season of eligibility
-
Ribeiro and Richie among celebrity birthdays for September 20–26
-
Florida State dismisses athletics director Alford and appoints interim leader
-
Bob Mackie, costume designer for Cher and Madonna, dies aged 87
-
Saudi Arabia warns it will react 'firmly' to Houthi attacks
-
Mahomes makes triumphant return as Chiefs rout Broncos 31-10
-
Designer Bob Mackie dies at 87 after career spanning television, stage and fashion
-
Belgium completes outer structure of offshore energy island
-
'Widow's Bay' and 'The Pitt' win big at Emmy Awards
-
Video documents rescue of injured US airman from Iran
-
China retail sales growth weakens further in August
-
Asian Games: Bigger than Olympics, young stars and a cruise ship
-
Eala to Yu Zidi: Six emerging stars set to light up Asian Games
-
Asian Games set for liftoff but will have everyone have a bed?
-
Brady and Bündchen’s former Brentwood estate combined luxury and resource-saving systems
-
Most markets drop as oil extends gains ahead of expected US rate hike
-
In Kashmir, lake weeds mix with traditional art
-
Kate Beckinsale challenges assumptions about her beauty routine
-
Chinese architect Ma Yansong melds nature with 'futuristic feel'
-
Sri Lanka's famed beach shack battles demolition
-
Trump says he will decide whether US pursues Iran deal
-
Drone shot down by NATO over Lithuania
-
'Widow's Bay' and 'The Pitt' take key Emmy awards
-
Vserv targets ₹1,000 crore revenue by 2030 through AI expansion
-
Television's A-listers glitter on Emmys red carpet
Ozempic-maker Novo Nordisk slims down to 'Novo'
Danish pharmaceuticals giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Monday a name change to just Novo, hoping it will be more "memorable and relevant" for clients.
The rebrand comes ahead of a strategic presentation on September 21, when executives are to lay out their plan for "a faster, more competitive and increasingly consumer-driven market".
The company is battling fierce competition in the anti-obesity sector, where its hugely successful Ozempic and Wegovy treatments have spurred rivals to catch up.
It released a new tablet form of Wegovy in the United States in January, and the pill was recently approved for use in Europe.
It will keep the full Novo Nordisk as its legal corporate name, using Novo and an updated version of its bull logo for its packaging.
Chief executive Mike Doustdar told Denmark's TV2 television the rebrand was part of an effort to "reinvent the company".
"People who use insulin are only considered as patients," he said.
"But over the past four or five years, we've seen the emergence of a bigger and bigger group that tells us, 'I'm not a patient, I'm not sick. I just want to lose weight'."
Ch.P.Lewis--AT
